focus -WSS

focus

author：comprehensive 2025-10-01 21:08:58 - browse：2718

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： MD Anderson's Padmanee Sharma responds to research credit suit

WSS

Patients, doctors press FTC to beef up hospital merger scrutiny

Opioid cravings were reduced by anti

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Medicare Advantage enrollment hits roughly 33.4 million

Transgender sports debate: Physicians say bans are health issue

Obamacare plans could cover weight loss drugs

explore

focus

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Eli Lilly CEO gives to Mike Pence presidential super PAC

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Congress may force more Covid

Virginia high school admissions case could be legal follow

Hospitals are piloting generative AI tools as regulators play catch

Tori Bowie and the unacceptable rates of Black maternal death

FDA weighs limits of animal data in assessing artificial wombs

How one medical school became remarkably diverse

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

entertainment

People with substance use disorder deserve online privacy

Congress may force more Covid

New study raises questions about niacin and heart health

Obamacare plans could cover weight loss drugs

New study raises questions about niacin and heart health

Opioid cravings were reduced by anti

entertainment

focus

hotspot

Wikipedia